Strides Pharma Science Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 45.31 | -100% | 28.62 | -100% |
| P/S |
|
1.76 | 5.02 | -64.99% |
|
|
| P/BV |
|
3.44 | 6.25 | -44.99% |
|
|
| P/FCF |
|
6.4 | 170.32 | -96.24% |
|
|
| Ev/Ebitda |
|
22.91 | 13.54 | 69.22% |
|
|
| Ev/S |
|
2.32 | 4.73 | -51.08% |
|
|
| Ev/FCF |
|
16.09 | 165.19 | -90.26% |
|
|
| E/P |
|
-0.0189 | 0.0451 | -141.9% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
2/10
|
5.92 | 22.04 | -73.16% | 8.66 | -31.66% |
| ROE |
|
-3.26 | 17.13 | -119% |
|
|
| ROA |
|
-1.13 | 10.35 | -110.94% |
|
|
| ROIC |
|
-3.79 | 10.89 | -134.83% |
|
|
| ROS |
|
-1.74 | 11.8 | -114.75% |
|
|
| ROCE |
|
6.62 | 18.81 | -64.79% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
0/10
|
11.07 | 1.25 | 784.84% | 5.61 | +97.11% |
| Nеt Debt/Ebitda |
|
10.33 | 1.05 | 884.33% |
|
|
| Debt/Ratio |
|
0.4135 | 0.1376 | 200.5% |
|
|
| Debt/Equity |
|
0.7178 | 0.8085 | -11.22% |
|
|
| Debt/Net Income |
|
-34.19 | 3.21 | -1164.92% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0.13/10
|
0.0512 | 12.08 | -99.58% | 0.3789 | -86.49% |
| Number of years of dividend growth |
|
0 | 1.26 | -100% | ||
| DSI |
|
0.8571 | 0.8404 | 1.99% |
|
|
| Average dividend growth |
|
-60.79 | -66.15 | -8.1% |
|
|
| Average percentage for 5 years |
|
0.3789 | 11.32 | -96.65% |
|
|
| Average percentage for payments |
|
17.41 | 30.57 | -43.04% |
|
|
| Difference from average difference in sector |
|
-12.03 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
6/10
|
49.63 | 87.3 | -43.15% | ||
| Growth impulse Ebitda in 5 years |
|
-46.65 | 45.31 | -202.96% | ||
| Growth impulse Net Income in 5 years |
|
-294.04 | 138.32 | -312.58% | ||
| Growth impulse FCF in 5 years |
|
964 | 82.83 | 1063.83% | ||
| Growth impulse EPS in 5 years |
|
-289.02 | 288.08 | -200.33% |
IP Score
3.39/10
